|
IMPA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.78010000470874E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40140000048916E-07 |
| Normal-vs-Stage2 |
9.75709999462282E-08 |
| Normal-vs-Stage3 |
1.70189999870729E-08 |
| Normal-vs-Stage4 |
1.48319999615509E-08 |
| Stage1-vs-Stage2 |
4.499200E-01 |
| Stage1-vs-Stage3 |
9.576500E-02 |
| Stage1-vs-Stage4 |
1.036410E-01 |
| Stage2-vs-Stage3 |
6.589400E-01 |
| Stage2-vs-Stage4 |
4.928000E-01 |
| Stage3-vs-Stage4 |
7.562200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.79620000382042E-08 |
| Normal-vs-AfricanAmerican |
4.42000000000498E-06 |
| Normal-vs-Asian |
9.19980003288856E-09 |
| Caucasian-vs-AfricanAmerican |
5.219600E-01 |
| Caucasian-vs-Asian |
1.615210E-01 |
| AfricanAmerican-vs-Asian |
1.426190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.60030000362354E-08 |
| Normal-vs-Female |
8.01149999674067E-08 |
| Male-vs-Female |
1.667180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.61920000022009E-07 |
| Normal-vs-Age(41-60Yrs) |
2.30279999513527E-08 |
| Normal-vs-Age(61-80Yrs) |
2.76339999771835E-08 |
| Normal-vs-Age(81-100Yrs) |
1.423870E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.876200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.241580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.876400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.729600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.986200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.876200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.034950E-01 |
| Classical-VS-Follicular |
6.116800E-01 |
| Classical-VS-Other |
4.459800E-01 |
| Classical-VS-Normal |
1.12830000009723E-07 |
| Tall-VS-Follicular |
7.044100E-02 |
| Tall-VS-Other |
2.483600E-01 |
| Tall-VS-Normal |
8.42860004013346E-09 |
| Follicular-VS-Other |
5.740200E-01 |
| Follicular-VS-Normal |
4.26689999999397E-07 |
| Other-VS-Normal |
6.206100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0636999947522E-08 |
| Normal-vs-N1 |
1.52350000000023E-05 |
| N0-vs-N1 |
1.651220E-01 |
|
|
